Table 4.
Support for judgment of risk of bias per item and study. Random sequence generation, allocation concealment, and blinding of outcome assessment.
Author, year | Random sequence generation | Allocation concealment | Blinding of outcome assessment |
Brannon et al, 2017 [48] | Unclear; Not enough information | Unclear; Not enough information | Unclear; Not enough information |
Chen et al, 2017 [49] | Low; Randomization using computer program | Unclear; Not enough information | Unclear; Not enough information |
Dewar et al, 2013 [50] | Unclear; Not enough information | Unclear; Not enough information | High; At baseline only. Outcomes likely to be influenced by lack of blinding |
Dewar et al, 2014 [51] | Unclear; Not enough information | Unclear; Not enough information | Unclear; Not enough information |
Ermetici et al, 2016 [52] | High; No randomization | High; No randomization | Unclear; Not enough information |
Lana et al, 2014 [60] | Low; Randomization using computer program | Unclear; Not enough information | Unclear; Not enough information |
Lau et al, 2012 [53] | High; No randomization | Unclear; Not enough information | Unclear; Not enough information |
Lubans et al, 2012 [54] | Unclear; Not enough information | Unclear; Not enough information | High; At baseline only. Outcomes likely to be influenced by lack of blinding |
Mendoza et al, 2017 [55] | Unclear; Not enough information | Unclear; Not enough information | High; Unblinded RCTa |
Newton et al, 2009 [56] | Unclear; Not enough information | Unclear; Not enough information | Low; Assessors blinded at follow-up |
Patrick et al, 2013 [57] | Unclear; Not enough information | Unclear; Not enough information | Unclear; Not enough information |
Sirriyeh et al, 2010 [58] | Low; Randomization using random number generator | Unclear; Not enough information | Low; Assessors blinded at follow-up |
Straker et al, 2014 [59] | High; Within-subject waitlist study design | High; Within-subject waitlist study design | High; Outcomes likely to be influenced by lack of blinding |
aRCT: randomized controlled trial.